Ask what each test will answer.

There is no universal test list here

As of September 2026, sermorelin has no current FDA label, the official drug information sheet reviewed by the US Food and Drug Administration.

There is no current FDA test checklist for sermorelin.

As of September 2026, general federal law on prescribing does not require a set of blood tests before a prescription.

That does not settle what state rules or sound care require in an individual case.

A useful discussion explains why tests are proposed, rather than treating a package name as the reason.

What the research measured

Studies of sermorelin and a similar medicine measured growth hormone, a body signal involved in growth, along with blood sugar, blood fats and IGF-1.

IGF-1 is another body signal involved in growth; growth hormone prompts the body to make it. Its blood level is one result a study can measure.

Those are tests the researchers used, rather than a set of tests required for every patient.

Ask what each blood result says about your health problem. Ask what else the doctor checks before using that result to suggest treatment.

Know how results will be reviewed

• Who will explain the results?
• What would change the proposed plan?
• Will the results reach my usual clinician?
• Are test fees included in the quoted price?

Get the review arrangements in writing. A result that arrives without an explanation can leave the main question unanswered.

Follow-up needs a clear purpose

Ask what will be reviewed after treatment starts: the original concern, any unwanted effects, and any tests the clinician considers relevant.

Ask when the plan will be revisited and what happens if the expected change does not occur. Keep a short record of questions for that discussion.

Avoid treating a hormone number as the whole goal. Ask how it connects to a result that matters to you.

Find the follow-up questions→